CS
BIIB icon

Credential Securities’s Biogen BIIB Stock Holding History

Credential Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$277K Sell
955
-143
-13% -$40.2K 0.06% 147
2018
Q1 		$301K Buy
1,098
+356
+48% +$111K 0.07% 149
2017
Q4 		$236K Sell
742
-109
-13% -$35K 0.06% 160
2017
Q3 		$266K Sell
851
-112
-12% -$33.2K 0.07% 155
2017
Q2 		$262K Buy
963
+842
+696% +$223K 0.08% 153
2017
Q1 		$33.1K Buy
+121
New +$34.2K 0.01% 222

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credential Securities's BIIB Position: Q2 2018 in Review

Credential Securities reduced its Biogen (BIIB) stake by 13% in Q2 2018, selling an estimated $40.2K and leaving 955 shares worth $277K. The position accounts for 0.06% of the portfolio, ranked #147.

Credential Securities first reported a position in BIIB in Q1 2017 and has held it in 6 quarters since. The position peaked at $301K in Q1 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Credential Securities held 955 shares of Biogen worth $277K as of Q2 2018.
  • Credential Securities sold 143 Biogen shares in Q2 2018, an estimated $40.2K.
  • Biogen made up 0.06% of Credential Securities's portfolio in Q2 2018, its #147 holding.
  • Credential Securities first reported a position in Biogen in Q1 2017 and has held it in 6 quarters since.
  • Credential Securities's Biogen position peaked at $301K in Q1 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.